Mei Lin Pang, MD
Pediatric Emergency Medicine · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 2
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pang’s office at (650) 934-7800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A93591 · Current
Licensed to practise in California · since 2005 · expires 2027-04-30 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$402,111 in 2024
Medicaid paid $402,111 for 5,814 billed services this clinician did in 2024, up to 160 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,702 | $391,246 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 336 | $3,179 |
| Developmental screening | 223 | $1,560 |
| Short return visit (20+ min) | 1,482 | $1,510 |
| Pure tone audiometry (threshold); air only | 321 | $846 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 169 | $725 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 68 | $723 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 28 | $600 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 95 | $560 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 82 | $499 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 43 | $288 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 37 | $181 |
| 2024 | 5,814 | 20 | 160 | $402,111 |
| 2023 | 7,311 | 24 | 163 | $404,643 |
| 2022 | 7,446 | 23 | 215 | $356,705 |
| 2021 | 4,420 | 18 | 194 | $334,011 |
| 2020 | 1,769 | 8 | 102 | $248,889 |
| 2019 | 1,217 | 3 | 54 | $218,399 |
| 2018 | 1,288 | 3 | 135 | $251,738 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,689 | $371,497 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 524 | $9,348 |
| Developmental screening | 276 | $4,947 |
| Pure tone audiometry (threshold); air only | 457 | $4,167 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 172 | $3,309 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 363 | $3,160 |
| Screening performed and negative | 688 | $1,914 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 331 | $1,786 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 115 | $1,760 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 25 | $544 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 140 | $516 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 80 | $435 |
2022
| Clinic visit/encounter, all-inclusive | 1,484 | $323,341 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 450 | $8,945 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 324 | $5,652 |
| Pure tone audiometry (threshold); air only | 501 | $3,761 |
| Developmental screening | 113 | $3,240 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 146 | $2,890 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 384 | $1,706 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 350 | $1,597 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 176 | $1,320 |
| Screening performed and negative | 875 | $1,103 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 157 | $843 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 144 | $645 |
2021
| Clinic visit/encounter, all-inclusive | 1,376 | $320,649 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 172 | $3,211 |
| Pure tone audiometry (threshold); air only | 420 | $3,090 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 69 | $1,944 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 123 | $1,681 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 37 | $1,405 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 248 | $770 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 105 | $378 |
| Short return visit | 654 | $322 |
| Short return visit (20+ min) | 511 | $297 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 20 | $90 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 20 | $50 |
2020
| Clinic visit/encounter, all-inclusive | 724 | $246,280 |
| Short return visit (20+ min) | 546 | $1,059 |
| Short return visit | 220 | $548 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 66 | $456 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 39 | $308 |
| Return visit (30+ min) | 118 | $238 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 14 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 42 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 639 | $216,271 |
| Short return visit (20+ min) | 512 | $1,733 |
| Return visit (30+ min) | 66 | $394 |
2018
| Clinic visit/encounter, all-inclusive | 757 | $249,098 |
| Short return visit (20+ min) | 420 | $2,022 |
| Return visit (30+ min) | 111 | $619 |
Professional record
- NPI
- 1366633141
- Licence
- CA A93591California A93591: Current · expires 2027-04-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207PP0204X (207PP0204X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-08-06
- NPI last updated
- 2011-09-29
This is when the NPI record was last certified, not a medical board exam.